Global incidence in hospital-associated infections resistant to antibiotics: An analysis of point prevalence surveys from 99 countries
PLOS Medicine · 13.06.2023 · 20 (6) · e1004178
DOI: 10.1371/journal.pmed.1004178 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Medicine, online erschienen am 13.06.2023. Verfasst von Ruchita Balasubramanian und 4 weiteren Autor:innen. Beteiligte Einrichtung: One Health Trust, New Delhi, India. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Cross Infection. Die Arbeit wurde bisher 140-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bill and Melinda Gates Foundation, National Science Foundation, Centers for Disease Control and Prevention.
Abstract (Originalsprache)
Background
Hospital-associated infections (HAIs) are an important cause of morbidity and mortality around the world. Many HAIs are caused by drug-resistant bacterial pathogens, but there are major gaps in our understanding of the number of hospital-associated drug-resistant infections (HARIs) worldwide. As such, we estimated trends in prevalence of HARIs caused by high priority pathogens ( Escherichia coli , Acinetobacter spp., Klebsiella spp., Staphylococcus aureus , Enterobacter spp., and Pseudomonas spp.) in 195 countries. Methods and findings Resistance prevalence estimates were extracted from 474-point prevalence surveys (PPS) from 99 countries published between 2010 and 2020 coupled with country-level estimates of hospitalization rates and length of stay. Prevalence estimates were transformed in yearly incidence of HARIs per year by country and income group. We estimate the global number of HARIs per year to be 136 million (95% credible interval (CI) 26 to 246 million) per year, with the highest burden in China (52 million, 95% CI 10 to 95 million), Pakistan (10 million, 95% CI 2 to 18 million), and India (9 million, 95% CI 3 to 15 million). Among income groups, middle-income countries bore the highest burden of HARIs per year (119 million, 95% CI 23 to 215 million). Our analysis was constrained by the limited number of PPS for HARIs, lack of community-associated data on antibiotic-resistant infections, and our population level analysis.
Conclusions
In this study, we observe, in the absence of systematic surveillance systems for HARIs, a baseline overview of their rates. Our yearly estimates highlight the global threat of HARIs and may help define strategies to tackle resistance in hospital settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- One Health Trust, New Delhi, India.
- Health Geography and Policy Group, ETH Zurich, Zurich, Switzerland.
- Division of Epidemiology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
- The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
- Princeton University, Princeton, New Jersey, United States of America.
ORCID-Profile: Ruchita Balasubramanian
Förderung
- Bill and Melinda Gates Foundation
- National Science Foundation
- Centers for Disease Control and Prevention
- Swiss National Science Foundation
Zitieren
APA
Balasubramanian, R., Van Boeckel, T. P., Carmeli, Y., Cosgrove, S., & Laxminarayan, R. (2023). Global incidence in hospital-associated infections resistant to antibiotics: An analysis of point prevalence surveys from 99 countries. PLOS Medicine, 20(6), e1004178. https://doi.org/10.1371/journal.pmed.1004178
Vancouver
Balasubramanian R, Van Boeckel TP, Carmeli Y, Cosgrove S, Laxminarayan R. Global incidence in hospital-associated infections resistant to antibiotics: An analysis of point prevalence surveys from 99 countries. PLOS Medicine. 2023;20(6):e1004178. doi:10.1371/journal.pmed.1004178
BibTeX
@article{Balasubramanian2023,
author = {Balasubramanian, Ruchita and Van Boeckel, Thomas P and Carmeli, Yehuda and Cosgrove, Sara and Laxminarayan, Ramanan},
title = {Global incidence in hospital-associated infections resistant to antibiotics: An analysis of point prevalence surveys from 99 countries},
journal = {PLOS Medicine},
year = {2023},
volume = {20},
number = {6},
pages = {e1004178},
doi = {10.1371/journal.pmed.1004178}
}
EUVIMED